about
Serum brain-derived neurotrophic factor, depression, and antidepressant medications: meta-analyses and implicationsHumoral sleep regulation; interleukin-1 and tumor necrosis factorCytokines in immune function and sleep regulation.Blood lipids and adipokines concentrations during a 6-month nutritional and physical activity intervention for metabolic syndrome treatment.Effects of combined exercise on cardiovascular risk factors and serum BDNF level in mid-aged womenMetabolic syndrome and neurotrophins: effects of metformin and non-steroidal antiinflammatory drug treatment.New function of the adaptor protein SH2B1 in brain-derived neurotrophic factor-induced neurite outgrowthBiochemical regulation of sleep and sleep biomarkersSerum brain-derived neurotrophic factor: determinants and relationship with depressive symptoms in a community population of middle-aged and elderly people.Central obesity, type 2 diabetes and insulin: exploring a pathway full of thorns.NGF, brain and behavioral plasticity.p75 and TrkA signaling regulates sympathetic neuronal firing patterns via differential modulation of voltage-gated currents.Nerve growth factor links oral cancer progression, pain, and cachexia.Chronic prehepatic portal hypertension in the rat: is it a type of metabolic inflammatory syndrome?The role of cytokines in sleep regulationThe effects of physical activity and exercise on brain-derived neurotrophic factor in healthy humans: A review.Testosterone deficiency, insulin-resistant obesity and cognitive function.Neuropathy-specific alterations in a Mexican population of diabetic patients.Insulin Resistance and Neurodegeneration: Progress Towards the Development of New Therapeutics for Alzheimer's Disease.Low BDNF is associated with cognitive deficits in patients with type 2 diabetes.Exercise training blunts microvascular rarefaction in the metabolic syndrome.Effects of Mucuna pruriens on Free Fatty Acid Levels and Histopathological Changes in the Brains of Rats Fed a High Fructose Diet.Decreased Serum Levels of Ghrelin and Brain-Derived Neurotrophic Factor in Premenopausal Women With Metabolic Syndrome.Selected Metabolic Markers in Girls with Turner Syndrome: A Pilot Study
P2860
Q24649095-F2CC07DA-C4B2-4D10-A617-E7898D7A62B2Q33648273-6CD38500-C692-43BA-ABFB-7DDAD4340F4BQ33716410-0A23A351-529E-4619-8697-F9E2D720493FQ34499487-3B776253-4665-4A6C-80F5-E52515DD0419Q34563472-6582804E-141D-4619-8167-2D99D53CE996Q34666789-883C0DA2-E7CD-4405-BB2D-4E6A53529AAAQ35048581-E5979DD8-B035-4BE5-866F-496B2C1591C5Q35306427-CCBB6918-4EC0-4228-800C-35C02FDB1277Q35755941-CED796D3-8024-4C2F-AF7B-5A2EE4B7E270Q35829203-3271FF12-FE57-4871-A09F-0FC8A320B71FQ35837997-ABF385DC-96FB-4E1D-A0EF-AF3FEC364676Q35888782-E8C3C09B-F104-4D4F-80EF-912564D9A9ADQ36031474-4230C3A9-AE2C-4260-90D7-EBF9895F13D1Q36487408-3FFF26F4-B881-424A-A24E-B1193BAB0269Q37347398-B00A5621-137C-4686-9DF0-40E75DAED75EQ38100227-69770069-2140-4EA9-B58C-F673910FF422Q38363704-48E6D796-293C-473D-BEE3-CFADAF5BF524Q38607985-0931E3FF-D569-4B56-AADE-C9F207F66700Q39042377-772A0DA8-11C8-46E2-9356-A5A96BB84216Q44345365-3BF2760B-AA8D-4F7D-A469-F6CA313FDD0BQ44921311-01933C70-434F-4F4D-A620-0F70CA686D03Q47642671-4305941B-55D6-4BEF-B148-1BFBE0BD08A9Q47853926-AFB6FE56-E8C4-4C80-B7B0-4E553A6AFCB3Q58693295-610E410F-E820-43BF-9B1C-72F54746790A
P2860
description
2005 nî lūn-bûn
@nan
2005 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Metabolic syndrome--neurotrophic hypothesis.
@ast
Metabolic syndrome--neurotrophic hypothesis.
@en
type
label
Metabolic syndrome--neurotrophic hypothesis.
@ast
Metabolic syndrome--neurotrophic hypothesis.
@en
prefLabel
Metabolic syndrome--neurotrophic hypothesis.
@ast
Metabolic syndrome--neurotrophic hypothesis.
@en
P1433
P1476
Metabolic syndrome--neurotrophic hypothesis.
@en
P2093
P304
P356
10.1016/J.MEHY.2005.08.055
P577
2005-11-18T00:00:00Z